Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: Safety, feasibility and preliminary clinical findings

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Zeira, Offer ^a   Asiag, Nimrod ^a   Aralla, Marina ^a   Ghezzi, Erica ^a   Pettinari, Letizia ^a   Martinelli, Laura ^a   Zahirpour, Daniele ^a   Dumas, Maria Pia ^a   Lupi, Davide ^a   Scaccia, Simone ^a   Konar, Martin ^a   Cantile, Carlo ^b  

^a Veterinary Hospital San Michele   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Central nervous system; Dog; Meningoencephalitis; Mesenchymal stem cells

Indexed keywords

CYTARABINE; ETIRACETAM; PHENOBARBITAL; PREDNISOLONE; PREDNISONE; ANTIINFLAMMATORY AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; ADVERSE OUTCOME; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAROTID ARTERY; CELL ISOLATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CISTERNA MAGNA; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; DOG DISEASE; DRUG DOSE REDUCTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; NECK PAIN; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SEIZURE; STEM CELL EXPANSION; TREATMENT RESPONSE; ANIMAL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DISEASE MODEL; DOG; DRUG EFFECTS; INFLAMMATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; DOGS; FEMALE; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84942512763     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0402-9     Document Type: Article

References (51)

1. Coates JR, Jeffery ND: Perspectives on meningoencephalomyelitis of unknown origin. Vet Clin Small Anim. 2014;44 (6):1157-1185.
2. Talarico LR, Schatzberg SJ. Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives. J Small Anim Pract. 2010;51:138-49.
3. Zarfoss M, Schatzberg S, Venator K, Cutter-Schatzberg K, Cuddon P, Pintar J, et al. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. J Small Anim Pract. 2006;47:588-95.
4. Bradley GA. Myocardial necrosis in a pug dog with necrotizing meningoencephalitis. Vet Pathol. 1991;28:91-3.
5. Cordy DR, Holliday TA. A necrotizing meningoencephalitis of pug dogs. Vet Pathol. 1989;26:191-4.
6. Fearnside SM, Kessell AE, Powe JR. Cervical hyperaesthesia in a Maltese terrier with necrotising meningoencephalitis. Aust Vet J. 2004;82:550-2.
7. Panciera DL, Duncan ID, Messing A. Magnetic resonance imaging in two dogs with central nervous system disease. J Small Anim Pract. 1987;28:587-96.
8. Suzuki M, Uchida K, Morozumi M, Hasegawa T, Yanai T, Nakayama H, et al. A comparative pathological study on canine necrotizing meningoencephalitis and granulomatous meningoencephalomyelitis. J Vet Med Sci. 2003;65:1233-9.
9. Higgins RJ, Dickinson PJ, Kube SA, Moore PF, Couto SS, Vernau KM, et al. Necrotizing meningoencephalitis in five Chihuahua dogs. Vet Pathol. 2008;45:336-46.
10. Cantile C, Chianini F, Arispici M, Fatzer R. Necrotizing meningoencephalitis associated with cortical hippocampal hamartia in a Pekingese dog. Vet Pathol. 2001;38:119-22.
11. Baiker K, Hofmann S, Fischer A, Gödde T, Medl S, Schmahl W, et al. Leigh-like subacute necrotising encephalopathy in Yorkshire terriers: neuropathological characterisation, respiratory chain activities and mitochondrial DNA. Acta Neuropathol. 2009;118:697-709.
12. Ducoté JM, Johnson KE, Dewey CW, Walker MA, Coates JR, Berridge BR. Computed tomography of necrotizing meningoencephalitis in 3 Yorkshire terriers. Vet Radiol Ultrasound. 1999;40:617-21.
13. Spitzbarth I, Schenk HC, Tipold A, Beineke A. Immunohistochemical characterization of inflammatory and glial responses in a case of necrotizing leukoencephalitis in a French bulldog. J Comp Pathol. 2010;142:235-41.
14. Granger N, Smith PM, Jeffery ND. Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J. 2010;184:290-7.
15. Kipar A, Baumgartner W, Vogl C, Gaedke K, Wellman M. Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet Pathol. 1998;35:43-52.
16. Thomas JB, Eger C. Granulomatous meningoencephalomyelitis in 21 dogs. J Small Anim Pract. 1989;30:287-93.
17. Barber RM, Li Q, Diniz PP, Porter BF, Breitschwerdt EB, Claiborne MK, et al. Evaluation of brain tissue or cerebrospinal fluid with broadly reactive polymerase chain reaction for Ehrlichia, Anaplasma, spotted fever group Rickettsia, Bartonella, and Borrelia species in canine neurological diseases (109 cases). J Vet Intern Med. 2010;24:372-8.
18. Barber RM, Porter BF, Li Q, May M, Claiborne MK, Allison AB, et al. Broadly reactive polymerase chain reaction for pathogen detection in canine granulomatous meningoencephalomyelitis and necrotizing meningoencephalitis. J Vet Intern Med. 2012;26:962-8.
19. Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci. 2001;21:4564-71.
20. Cardoso R, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 2010;64:328-64.
21. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48-65.
22. Nuhsbaum MT, Powell CC, Gionfriddo JR, Cuddon PA. Treatment of granulomatous meningoencephalomyelitis in a dog. Vet Ophtalmol. 2002;5:29-33.
23. Menaut P, Landart J, Behr S, Lanore D, Trumel C. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside. Vet Rec. 2008;162:241-5.
24. Boucherie C, Schafer S, Lavand'homme P, Maloteaux JM, Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2009;87:2034-46.
25. Chao YX, He BP, Tay SS. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol. 2009;216:39-50.
26. Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia. 2005;49:407-17.
27. Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS One. 2011;6(5):e19808.
28. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076-84.
29. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11-5.
30. Meirelles LS, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20:419-27.
31. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007;40:609-19.
32. Zhou C, Zhang C, Chi S, Xu Y, Teng J, Wang H, et al. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res. 2009;1269:23-30.
33. Abrams MB, Dominguez C, Pernold K, Reger R, Wiesenfeld-Hallin Z, Olson L, et al. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci. 2009;27:307-21.
34. Musolino PL, Coronel MF, Hokfelt T, Villar MJ. Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett. 2007;418:97-101.
35. Siniscalco D, Giordano C, Galderisi U, Luongo L, Alessio N, Di Bernardo G, et al. Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci. 2010;67:655-69.
36. Linee guida concernenti i requisiti sanitari minimi per l'impiego delle cellule staminali in medicina veterinaria. Rep Atti n. 147/CSR del 17 ottobre 2013
37. Brown ML, Korol B. Surgical preparation of externalized carotid artery loops in dogs. Physiol Behav. 1968;3(1):207-8.
38. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol. 1999;100:74-97.
39. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2:797-804.
40. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-8.
41. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010;133:1655-67.
42. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735-9.
43. Stein VM, Baumgartner W, Kreienbrock L, Zurbriggen A, Vandevelde M, Tipold A. Canine microglial cells: stereotypy in immunophenotype and specificity in function? Vet Immunol Immunopathol. 2006;113:277-87.
44. Boekhoff TM, Ensinger EM, Calrson R, Bock P, Baumgärtner W, Rohn K, et al. Microglial contribution to secondary injury evaluated in a large animal model of human spinal cord trauma. J Neurotrauma. 2012;29:1000-11.
45. Spitzbarth I, Baumgartner W, Beineke A. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine diseases. Vet Immunol Immunopathol. 2012;147:6-24.
46. Beineke A, Markus S, Borlak J, Thum T, Baumgärtner W. Increase of pro-inflammatory cytokine expression in non-demyelinating early cerebral lesions in nervous canine distemper. Viral Immunol. 2008;21:401-10.
47. Beineke A, Puff C, Seehusen F, Baumgärtner W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol. 2009;127:1-18.
48. Wang Kimbrel EA, Ijichi K, Paul D, Lazorchak AS, Chu J, Kouris NA, et al. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports. 2014;3(1):115-30.
49. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology. 2008;71:1647-8.
50. Barajas RF, Collins DE, Cha S, Geschwind MD. Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody. Epilepsia. 2010;51:473-7.
51. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69:892-900.